The hypothesis that ACE2 expression levels and dynamics affects Covid-19 severity is further supported by the observation that medical conditions that can affect the ACE2 expression levels such as hypertension, diabetes and obesity, but also genetic predisposition and certain medications, are known risk factors for severe disease phenotypes of Covid-19 [18]. This evidence concerns the gene ACE2 and obesity due to melanocortin 4 receptor deficiency.